ITGB3 and breast carcinoma: Finally, our results are consistent with data showing that genetic interference and pharmacological targeting of αv integrin (the partner of ITGB3) with the non-peptide RGD antagonist GLPG0187 in different breast cancer cell lines inhibits invasion and metastasis in the zebrafish or in a mouse xenograft model.